Back to Search Start Over

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens

Authors :
Fulvio Basolo
Sinchita Roy-Chowdhuri
Gilda da Cunha Santos
Giancarlo Troncone
Clara Mayo-de-las-Casas
Carlos E. de Andrea
Dario de Biase
Alessandra Rappa
Pasquale Pisapia
Sara Vander Borght
Lukas Bubendorf
Fernando Schmitt
Rajyalakshmi Luthra
Suzanne Kamel-Reid
Giovanni Tallini
Miguel Angel Molina-Vila
Elena Vigliar
Massimo Barberis
Lynette M. Sholl
Massimo Bongiovanni
Maria D. Lozano
Daniel Stieber
Gabriella Fontanini
Manuel Salto-Tellez
Umberto Malapelle
Philippe Vielh
Edoardo Missiaglia
Claudio Bellevicine
Francesco Pepe
Michel Bihl
Marina N. Nikiforova
Yuri E. Nikiforov
Rafael Rosell
Nicola Serra
David H. Hwang
Birgit Weynand
Massimo Rugge
Spasenija Savic
Matteo Fassan
Source :
Cancer Cytopathology. 125:615-626
Publication Year :
2017
Publisher :
Wiley, 2017.

Abstract

BACKGROUND Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor receptor (EGFR), emerging predictive/prognostic genomic biomarkers such as Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma RAS viral [v-ras] oncogene homolog (NRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA). Next-generation sequencing (NGS) and other multigene mutational assays are suitable for cytological specimens, including smears. However, the current literature reflects single-institution studies rather than multicenter experiences. METHODS Quantitative cytological molecular reference slides were produced with cell lines designed to harbor concurrent mutations in the EGFR, KRAS, NRAS, BRAF, and PIK3CA genes at various allelic ratios, including low allele frequencies (AFs; 1%). This interlaboratory ring trial study included 14 institutions across the world that performed multigene mutational assays, from tissue extraction to data analysis, on these reference slides, with each laboratory using its own mutation analysis platform and methodology. RESULTS All laboratories using NGS (n = 11) successfully detected the study's set of mutations with minimal variations in the means and standard errors of variant fractions at dilution points of 10% (P = .171) and 5% (P = .063) despite the use of different sequencing platforms (Illumina, Ion Torrent/Proton, and Roche). However, when mutations at a low AF of 1% were analyzed, the concordance of the NGS results was low, and this reflected the use of different thresholds for variant calling among the institutions. In contrast, laboratories using matrix-assisted laser desorption/ionization–time of flight (n = 2) showed lower concordance in terms of mutation detection and mutant AF quantification. CONCLUSIONS Quantitative molecular reference slides are a useful tool for monitoring the performance of different multigene mutational assays, and this could lead to better standardization of molecular cytopathology procedures. Cancer Cytopathol 2017;125:615-26. © 2017 American Cancer Society.

Details

ISSN :
1934662X
Volume :
125
Database :
OpenAIRE
Journal :
Cancer Cytopathology
Accession number :
edsair.doi...........e82c7675a160c75c8f6ac959e175e5d5
Full Text :
https://doi.org/10.1002/cncy.21868